Risk Score to Predict 1-Year Mortality after Haemodialysis Initiation in Patients with Stage 5 Chronic Kidney Disease under Predialysis Nephrology Care
PLoS ONE 10 巻 6 号
e0129180- 頁
2015-06-09 発行
アクセス数 : 557 件
ダウンロード数 : 134 件
今月のアクセス数 : 12 件
今月のダウンロード数 : 7 件
この文献の参照には次のURLをご利用ください : https://ir.lib.hiroshima-u.ac.jp/00047657
ファイル情報(添付) |
PLoSONE_10_e0129180.pdf
388 KB
種類 :
全文
|
タイトル ( eng ) |
Risk Score to Predict 1-Year Mortality after Haemodialysis Initiation in Patients with Stage 5 Chronic Kidney Disease under Predialysis Nephrology Care
|
作成者 |
Yamamoto Suguru
Morinaga Takatoshi
Sada Ken-ei
Kurita Noriaki
Onishi Yoshihiro
|
収録物名 |
PLoS ONE
|
巻 | 10 |
号 | 6 |
開始ページ | e0129180 |
抄録 |
Background
Few risk scores are available for predicting mortality in chronic kidney disease (CKD) patients undergoing predialysis nephrology care. Here, we developed a risk score using predialysis nephrology practice data to predict 1-year mortality following the initiation of haemodialysis (HD) for CKD patients. Methods This was a multicenter cohort study involving CKD patients who started HD between April 2006 and March 2011 at 21 institutions with nephrology care services. Patients who had not received predialysis nephrology care at an estimated glomerular filtration rate (eGFR) of approximately 10 mL/min per 1.73 m2 were excluded. Twenty-nine candidate predictors were selected, and the final model for 1-year mortality was developed via multivariate logistic regression and was internally validated by a bootstrapping technique. Results A total of 688 patients were enrolled, and 62 (9.0%) patients died within one year of HD initiation. The following variables were retained in the final model: eGFR, serum albumin, calcium, Charlson Comorbidity Index excluding diabetes and renal disease (modified CCI), performance status (PS), and usage of erythropoiesis-stimulating agent (ESA). Their β-coefficients were transformed into integer scores: three points were assigned to modified CCI3 and PS 3–4; two to calcium>8.5 mg/dL, modified CCI 1–2, and no use of ESA; and one to albumin<3.5 g/dL, eGFR>7 mL/min per 1.73 m2, and PS 1–2. Predicted 1-year mortality risk was 2.5% (score 0–4), 5.5% (score 5–6), 15.2% (score 7–8), and 28.9% (score 9–12). The area under the receiver operating characteristic curve was 0.83 (95% confidence interval, 0.79–0.89). Conclusions We developed a simple 6-item risk score predicting 1-year mortality after the initiation of HD that might help nephrologists make a shared decision with patients and families regarding the initiation of HD. |
内容記述 |
This work was supported by grants from the Institute for Health Outcomes & Process Evaluation research.
|
言語 |
英語
|
資源タイプ | 学術雑誌論文 |
出版者 |
Public Library of Science
|
発行日 | 2015-06-09 |
権利情報 |
© 2015 Doi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
|
出版タイプ | Version of Record(出版社版。早期公開を含む) |
アクセス権 | オープンアクセス |
収録物識別子 |
[ISSN] 1932-6203
[DOI] 10.1371/journal.pone.0129180
[DOI] https://doi.org/10.1371/journal.pone.0129180
|